Literature DB >> 8401008

Iron and coronary heart disease.

M J Burt, J W Halliday, L W Powell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8401008      PMCID： PMC1678944          DOI： 10.1136/bmj.307.6904.575

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

Review 2.  The iron paradigm of ischemic heart disease.

Authors:  J L Sullivan
Journal:  Am Heart J       Date:  1989-05       Impact factor: 4.749

Review 3.  Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis.

Authors:  B Halliwell
Journal:  Br J Exp Pathol       Date:  1989-12

4.  Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene.

Authors:  R A Riemersma; D A Wood; C C Macintyre; R A Elton; K F Gey; M F Oliver
Journal:  Lancet       Date:  1991-01-05       Impact factor: 79.321

5.  Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts.

Authors:  R E Williams; J L Zweier; J T Flaherty
Journal:  Circulation       Date:  1991-03       Impact factor: 29.690

6.  Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.

Authors:  T E Carew; D C Schwenke; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

7.  Autoantibody against oxidised LDL and progression of carotid atherosclerosis.

Authors:  J T Salonen; S Ylä-Herttuala; R Yamamoto; S Butler; H Korpela; R Salonen; K Nyyssönen; W Palinski; J L Witztum
Journal:  Lancet       Date:  1992-04-11       Impact factor: 79.321

8.  Iron stores and the international variation in mortality from coronary artery disease.

Authors:  R B Lauffer
Journal:  Med Hypotheses       Date:  1991-06       Impact factor: 1.538

9.  High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men.

Authors:  J T Salonen; K Nyyssönen; H Korpela; J Tuomilehto; R Seppänen; R Salonen
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690

10.  Factors affecting the concentrations of ferritin in serum in a healthy Australian population.

Authors:  B A Leggett; N N Brown; S J Bryant; L Duplock; L W Powell; J W Halliday
Journal:  Clin Chem       Date:  1990-07       Impact factor: 8.327
  10 in total
  5 in total

1.  Is increased tissue ferritin a risk factor for atherosclerosis and ischaemic heart disease?

Authors:  J F Koster; W Sluiter
Journal:  Br Heart J       Date:  1995-03

2.  Iron and coronary heart disease. Control for haematological variables.

Authors:  I F Godsland; R Bruce; M Worthington; J C Stevenson
Journal:  BMJ       Date:  1993-10-23

3.  Iron and coronary heart disease. Iron linked to immune activation.

Authors:  G Weiss; G Reibnegger; C Murr; H Wachter; D Fuchs
Journal:  BMJ       Date:  1993-10-23

4.  Iron and coronary heart disease. Iron makes myocardium vulnerable to ischemia.

Authors:  J L Sullivan
Journal:  BMJ       Date:  1993-10-23

5.  Vitamins, selenium, iron, and coronary heart disease risk in Indians, Malays, and Chinese in Singapore.

Authors:  K Hughes; C N Ong
Journal:  J Epidemiol Community Health       Date:  1998-03       Impact factor: 3.710
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.